We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Oncology

Journal Scan / Research · September 19, 2020

Effectiveness of Chemotherapy After Anti–PD‐1 Blockade Failure for Relapsed/Refractory Hodgkin Lymphoma

Cancer Medicine

 

Additional Info

Cancer Medicine
Effectiveness of Chemotherapy After Anti‐PD‐1 Blockade Failure for Relapsed and Refractory Hodgkin Lymphoma
Cancer Med 2020 Sep 02;[EPub Ahead of Print], B Casadei, L Argnani, A Morigi, G Lolli, A Broccoli, C Pellegrini, L Nanni, V Stefoni, PE Coppola, M Carella, M Cavo, PL Zinzani

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading